{
  "$schema": "folio-library-document/v1",
  "id": "10665-44796-ara",
  "title": "Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits (العربية)",
  "variant": "pdf",
  "pages": 68,
  "tocSource": "inferred",
  "tocMethod": "font",
  "toc": [
    {
      "level": 1,
      "title": "اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "number": null,
      "page": 3,
      "pageLabel": "i",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-000-اﻹﻃﺎر-اﻟﺨﺎص-ﺑﺎﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ"
    },
    {
      "level": 2,
      "title": "اﳌﺤﺘـﻮﻳــﺎت",
      "number": null,
      "page": 5,
      "pageLabel": "iii",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-001-اﳌﺤﺘـﻮﻳــﺎت"
    },
    {
      "level": 1,
      "title": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔH5N1 ﻣﻦ اﻟﻨﻤﻂ",
      "number": "12",
      "page": 5,
      "pageLabel": "iii",
      "confidence": 0.9,
      "evidence": [
        "style",
        "number",
        "numbered-style"
      ],
      "source": "inferred",
      "section": "sec-002-12-وﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا-اﻷﺧﺮى-اﻟﺘﻲ-ﻗﺪ-ﺗﺴﺒﺐ-ﺟﺎﺋﺤﺔ-ﺑ"
    },
    {
      "level": 2,
      "title": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
      "number": null,
      "page": 7,
      "pageLabel": "1",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-003-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﺗﺒﺎدل-ﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا"
    },
    {
      "level": 2,
      "title": "١– اﳌﺒﺎدئ",
      "number": null,
      "page": 9,
      "pageLabel": "3",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-004-١-اﳌﺒﺎدئ"
    },
    {
      "level": 2,
      "title": "٢– اﻟﻐﺮض",
      "number": null,
      "page": 12,
      "pageLabel": "6",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-005-٢-اﻟﻐﺮض"
    },
    {
      "level": 2,
      "title": "٤– اﻟﺘﻌﺎرﻳﻒ واﳌﺼﻄﻠﺤﺎت",
      "number": null,
      "page": 14,
      "pageLabel": "8",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-006-٤-اﻟﺘﻌﺎرﻳﻒ-واﳌﺼﻄﻠﺤﺎت"
    },
    {
      "level": 3,
      "title": "أﺳامء اﳌﺆﺳﺴﺎت واﳌﻨﻈامت واﻟﻜﻴﺎﻧﺎت",
      "number": null,
      "page": 16,
      "pageLabel": "10",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-007-أﺳامء-اﳌﺆﺳﺴﺎت-واﳌﻨﻈامت-واﻟﻜﻴﺎﻧﺎت"
    },
    {
      "level": 2,
      "title": "٥– ﻧﻈﺎم اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﻦ أﺟﻞ ﺗﺒﺎدل وﻓريوﺳﺎت H5N1 ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ",
      "number": null,
      "page": 18,
      "pageLabel": "12",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-008-٥-ﻧﻈﺎم-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﻣﻦ-أﺟﻞ-ﺗﺒﺎدل-وﻓر"
    },
    {
      "level": 3,
      "title": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ",
      "number": null,
      "page": 18,
      "pageLabel": "12",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-009-اﻷﺣﻜﺎم-اﻟﻌﺎﻣﺔ"
    },
    {
      "level": 3,
      "title": "ﺻﻴﻎ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد",
      "number": null,
      "page": 20,
      "pageLabel": "14",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-010-ﺻﻴﻎ-اﻻﺗﻔﺎق-اﳌﻮﺣﺪ-ﻟﻨﻘﻞ-اﳌﻮاد"
    },
    {
      "level": 3,
      "title": "ﺗﻨﺴﻴﻖ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﻠﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "number": null,
      "page": 22,
      "pageLabel": "16",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-011-ﺗﻨﺴﻴﻖ-ﻣﻨﻈﻤﺔ-اﻟﺼﺤﺔ-اﻟﻌﺎﳌﻴﺔ-ﻟﻠﺘﺄﻫﺐ-واﻟﺘﺼﺪي-ﻟﻸﻧﻔﻠﻮﻧ"
    },
    {
      "level": 3,
      "title": "ﺑﻨﺎء اﻟﻘﺪرات اﻟﺘﻨﻈﻴﻤﻴﺔ",
      "number": null,
      "page": 24,
      "pageLabel": "18",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-012-ﺑﻨﺎء-اﻟﻘﺪرات-اﻟﺘﻨﻈﻴﻤﻴﺔ"
    },
    {
      "level": 3,
      "title": "٦–٠١ إﺗﺎﺣﺔ اﻟﻠﻘﺎﺣﺎت ﰲ اﻟﻔﱰة اﻟﻔﺎﺻﻠﺔ ﺑني أي ﺟﺎﺋﺤﺘني ﰲ اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ",
      "number": null,
      "page": 26,
      "pageLabel": "20",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-013-٦٠١-إﺗﺎﺣﺔ-اﻟﻠﻘﺎﺣﺎت-ﰲ-اﻟﻔﱰة-اﻟﻔﺎﺻﻠﺔ-ﺑني-أي-ﺟﺎﺋﺤﺘن"
    },
    {
      "level": 2,
      "title": "٧– ﺗﴫﻳﻒ اﻟﺸﺆون، واﻻﺳﺘﻌﺮاض",
      "number": null,
      "page": 29,
      "pageLabel": "23",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-014-٧-ﺗﴫﻳﻒ-اﻟﺸﺆون-واﻻﺳﺘﻌﺮاض"
    },
    {
      "level": 3,
      "title": "رﺻﺪ واﺳﺘﻌﺮاض اﻹﻃﺎر",
      "number": null,
      "page": 31,
      "pageLabel": "25",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-015-رﺻﺪ-واﺳﺘﻌﺮاض-اﻹﻃﺎر"
    },
    {
      "level": 1,
      "title": "اﳌـﻼﺣــﻖ",
      "number": null,
      "page": 33,
      "pageLabel": "147",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-016-اﳌـﻼﺣــﻖ"
    },
    {
      "level": 2,
      "title": "اﳌﻠﺤﻖ ١",
      "number": null,
      "page": 35,
      "pageLabel": "29",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-017-اﳌﻠﺤﻖ-١"
    },
    {
      "level": 3,
      "title": "اﳌﺎدة ٦– ﺣﻘﻮق اﳌﻠﻜﻴﺔ اﻟﻔﻜﺮﻳﺔ",
      "number": null,
      "page": 37,
      "pageLabel": "31",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-018-اﳌﺎدة-٦-ﺣﻘﻮق-اﳌﻠﻜﻴﺔ-اﻟﻔﻜﺮﻳﺔ"
    },
    {
      "level": 2,
      "title": "اﳌﻠﺤﻖ ٢",
      "number": null,
      "page": 39,
      "pageLabel": "33",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-019-اﳌﻠﺤﻖ-٢"
    },
    {
      "level": 3,
      "title": "اﳌﺎدة ٥– ﻓﺾ اﻟﻨﺰاﻋﺎت",
      "number": null,
      "page": 41,
      "pageLabel": "35",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-020-اﳌﺎدة-٥-ﻓﺾ-اﻟﻨﺰاﻋﺎت"
    },
    {
      "level": 2,
      "title": "اﳌﻠﺤﻖ ٣",
      "number": null,
      "page": 43,
      "pageLabel": "37",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-021-اﳌﻠﺤﻖ-٣"
    },
    {
      "level": 3,
      "title": "٣– ﺗﻌﻴني اﻷﻋﻀﺎء",
      "number": null,
      "page": 45,
      "pageLabel": "39",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-022-٣-ﺗﻌﻴني-اﻷﻋﻀﺎء"
    },
    {
      "level": 2,
      "title": "اﳌﻠﺤﻖ ٥",
      "number": null,
      "page": 48,
      "pageLabel": "42",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-023-اﳌﻠﺤﻖ-٥"
    },
    {
      "level": 3,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "page": 50,
      "pageLabel": "44",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-024-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ"
    },
    {
      "level": 3,
      "title": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
      "number": null,
      "page": 55,
      "pageLabel": "49",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-025-اﳌﺮاﻛﺰ-اﻟﻮﻃﻨﻴﺔ-اﳌﻌﻨﻴﺔ-ﺑﺎﻷﻧﻔﻠﻮﻧﺰا"
    },
    {
      "level": 4,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "page": 57,
      "pageLabel": "51",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-026-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ"
    },
    {
      "level": 3,
      "title": "H5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ",
      "number": null,
      "page": 59,
      "pageLabel": "53",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-027-h5-اﳌﺨﺘﱪات-اﳌﺮﺟﻌﻴﺔ-اﻟﺘﺎﺑﻌﺔ-ﻟﻠﻤﻨﻈﻤﺔ-واﳌﻌﻨﻴﺔ-ﺑﺎﻟﻨﻤ"
    },
    {
      "level": 4,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "number": null,
      "page": 59,
      "pageLabel": "53",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-028-اﻻﺧﺘﺼﺎﺻﺎت-اﳌﺘﻌﻠﻘﺔ-ﺑﺎﻟﺘﻌﺎﻣﻞ-ﻣﻊ-اﳌﻮاد-اﻟﺒﻴﻮﻟﻮﺟﻴﺔ-ا"
    },
    {
      "level": 4,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "page": 61,
      "pageLabel": "55",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-029-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ"
    },
    {
      "level": 3,
      "title": "اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "page": 63,
      "pageLabel": "57",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-030-اﳌﺨﺘﱪات-اﻟﺘﻨﻈﻴﻤﻴﺔ-اﻷﺳﺎﺳﻴﺔ"
    },
    {
      "level": 4,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "page": 65,
      "pageLabel": "59",
      "confidence": 0.6,
      "evidence": [
        "style"
      ],
      "source": "inferred",
      "section": "sec-031-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 3,
      "labelStart": "i",
      "labelEnd": "i",
      "words": 13,
      "summary": {
        "text": "The Arabic title page of WHO's Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻟﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت رواﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
      "extractCut": false,
      "blocks": [
        "library/10665-44796-ara/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-اﻹﻃﺎر-اﻟﺨﺎص-ﺑﺎﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ",
      "number": null,
      "title": "اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 5,
      "labelStart": "i",
      "labelEnd": "iii",
      "words": 316,
      "summary": {
        "text": "The cataloguing and copyright page of the Arabic edition of the Pandemic Influenza Preparedness (PIP) Framework, with ISBN, WHO copyright and standard disclaimers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        },
        {
          "term": "inﬂuenza",
          "heading": false
        },
        {
          "term": "اﳌﻮاد",
          "heading": false
        },
        {
          "term": "ﻛﺎن",
          "heading": false
        },
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": true
        },
        {
          "term": "اﻟﺤﺼﻮل",
          "heading": false
        },
        {
          "term": "اﻟﺠﺎﺋﺤﺔ",
          "heading": true
        }
      ],
      "extract": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻟﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى WHO Library Cataloguing-in-Publication Data Pandemic inﬂuenza preparedness framework for the sharing of inﬂuenza viruses and access to vaccines and other beneﬁts. 1. Inﬂuenza, Human – prevention and control. 2. Inﬂuenza, Human – virology 3. Orthomyxoviridae – isolation and puriﬁcation. 4. Inﬂuenza vaccines. 5. Pandemics. 6. Health",
      "extractCut": true
    },
    {
      "id": "sec-001-اﳌﺤﺘـﻮﻳــﺎت",
      "number": null,
      "title": "اﳌﺤﺘـﻮﻳــﺎت",
      "level": 2,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "iii",
      "labelEnd": "iii",
      "words": 58,
      "summary": {
        "text": "The first part of the table of contents, listing the framework's principles, objective, scope, definitions and the virus-sharing system.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﺗﺒﺎدل ﻓريوﺳﺎت",
          "heading": false
        }
      ],
      "extract": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا 1 واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى 3 ١– اﳌﺒﺎدئ 6 ٢– اﻟﻐﺮض 7 ٣– اﻟﻨﻄﺎق 8 ٤– اﻟﺘﻌﺎرﻳﻒ واﳌﺼﻄﻠﺤﺎت 8 اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ٤–١ 8 اﳌﺼﻄﻠﺤﺎت اﻟﺘﻘﻨﻴﺔ اﻷﺧﺮى ٤–٢ 10 أﺳامء اﳌﺆﺳﺴﺎت واﳌﻨﻈامت واﻟﻜﻴﺎﻧﺎت ٤–٣ 11 اﳌﺼﻄﻠﺤﺎت اﻷﺧﺮى ٤–٤ ٥– ﻧﻈﺎم اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﻦ أﺟﻞ ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
      "extractCut": false
    },
    {
      "id": "sec-002-12-وﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا-اﻷﺧﺮى-اﻟﺘﻲ-ﻗﺪ-ﺗﺴﺒﺐ-ﺟﺎﺋﺤﺔ-ﺑ",
      "number": "12",
      "title": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔH5N1 ﻣﻦ اﻟﻨﻤﻂ",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 7,
      "labelStart": "iii",
      "labelEnd": "1",
      "words": 270,
      "summary": {
        "text": "The rest of the table of contents, covering the virus-sharing provisions, the benefit-sharing system, governance and the annexes, followed by the heading of World Health Assembly resolution WHA64.5 of May 2011.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻮاد اﳌﻠﺤﻖ",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        },
        {
          "term": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ",
          "heading": false
        },
        {
          "term": "اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ",
          "heading": false
        },
        {
          "term": "ﻟﻨﻘﻞ اﳌﻮاد",
          "heading": false
        }
      ],
      "extract": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔH5N1 ﻣﻦ اﻟﻨﻤﻂ 12 اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ ٥–١ 13 ﺑﻴﺎﻧﺎت اﳌﺘﻮاﻟﻴﺎت اﻟﺠﻴﻨﻴﺔ ٥–٢ 13 آﻟﻴﺎت اﻟﺘﺘﺒﻊ واﻟﺘﺒﻠﻴﻎ ٥–٣ 14 ﺻﻴﻎ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد ٥–٤ 15 ٦– ﻧﻈﺎم ﺗﺒﺎدل ﻓﻮاﺋﺪ اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ 15 اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ ٦–٠ 16 ﺗﻨﺴﻴﻖ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﻠﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ٦–١ 16 ﺗﻘﺪﻳﺮ اﺣﺘامﻻت ﺣﺪوث اﻟﺠﺎﺋﺤﺔ واﻟﺘﺼﺪي ﻟﻠﻤﺨﺎﻃﺮ ٦–٢ 16 ﺗﻮرﻳﺪ ﻓريوﺳﺎت اﻟﻠﻘﺎﺣﺎت اﳌﺮﺷﺤﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ",
      "extractCut": true
    },
    {
      "id": "sec-003-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﺗﺒﺎدل-ﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا",
      "number": null,
      "title": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
      "level": 2,
      "pageStart": 7,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "3",
      "words": 250,
      "summary": {
        "text": "World Health Assembly resolution WHA64.5, which adopts the PIP Framework, recognises industry's role and asks the Director-General to implement, monitor and report on it every two years.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": true
        },
        {
          "term": "اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ",
          "heading": true
        },
        {
          "term": "واﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
          "heading": true
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ",
          "heading": true
        },
        {
          "term": "ﺗﺒﺎدل ﻓريوﺳﺎت",
          "heading": true
        },
        {
          "term": "ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ",
          "heading": false
        },
        {
          "term": "اﻹﻃﺎر اﻟﺨﺎص",
          "heading": false
        }
      ],
      "extract": "واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى ،ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ اﻟﺮاﺑﻌﺔ واﻟﺴﺘﻮن وﻗﺪ ﻧﻈﺮت ﰲ ﺗﻘﺮﻳﺮ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء اﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى؛١ وإذ ﺗﻌﱰف ﺑﺎﻟﻌﻤﻞ اﻟﺬي اﺿﻄﻠﻊ ﺑﻪ اﻟﺮﺋﻴﺴﺎن اﳌﺸﺎرﻛﺎن وأﻋﻀﺎء ﻣﻜﺘﺐ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ؛ وإذ ﺗﺮﺣﺐ ﺑﺤﺼﻴﻠﺔ ﻋﻤﻞ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء واﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل",
      "extractCut": true
    },
    {
      "id": "sec-004-١-اﳌﺒﺎدئ",
      "number": null,
      "title": "١– اﳌﺒﺎدئ",
      "level": 2,
      "pageStart": 9,
      "pageEnd": 12,
      "labelStart": "3",
      "labelEnd": "6",
      "words": 698,
      "summary": {
        "text": "Sets out the principles agreed by WHO Member States, recalling earlier resolutions and noting the threat of a pandemic, especially for developing countries. It commits states to share H5N1 and other potential pandemic influenza viruses and their benefits on an equal footing, and recognises the sovereign right over biological resources, the importance of technology transfer and the need to fund access to vaccines in developing countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "وﺗﻌﱰف ﺑﺄن",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﻨﺎﻣﻴﺔ وﺗﻌﱰف",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﺪول اﻷﻋﻀﺎء",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        }
      ],
      "extract": "ﻋﻨﺪﻣﺎ ﻳﺘﻌﻠﻖ اﻷﻣﺮ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى ﻓﺈن اﻟﺪول اﻷﻋﻀﺎء ﰲ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ: ﺗﺬﻛﱢﺮ ﺑﻘﺮار ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ج ص ع٠٦–٨٢ ﺑﺸﺄن اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت )١( اﻷﻧﻔﻠﻮﻧﺰا واﻟﺤﺼﻮل ﻋﲆ اﻟﻠﻘﺎﺣﺎت وﻏري ذﻟﻚ ﻣﻦ اﻟﻔﻮاﺋﺪ؛ وﺗﺸري إﱃ اﺳﺘﻤﺮار اﺣﺘامﻻت ﺣﺪوث ﺟﺎﺋﺤﺔ أﻧﻔﻠﻮﻧﺰا ﻗﺪ ﺗﱰﺗﺐ ﻋﻠﻴﻬﺎ آﺛﺎر ﺻﺤﻴﺔ واﻗﺘﺼﺎدﻳﺔ واﺟﺘامﻋﻴﺔ )٢( ﻣﺪﻣﺮة وﺧﺎﺻﺔ ﻟﻠﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ اﻟﺘﻲ ﺗﻌﺎين",
      "extractCut": true
    },
    {
      "id": "sec-005-٢-اﻟﻐﺮض",
      "number": null,
      "title": "٢– اﻟﻐﺮض",
      "level": 2,
      "pageStart": 12,
      "pageEnd": 14,
      "labelStart": "6",
      "labelEnd": "8",
      "words": 116,
      "summary": {
        "text": "States the framework's objective of improving pandemic preparedness through a fair, transparent and equitable system for sharing H5N1 and other potential pandemic viruses and the benefits. It defines its scope as excluding seasonal influenza and non-influenza pathogens.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "ﻫﺬا اﻹﻃﺎر",
          "heading": false
        },
        {
          "term": "اﻷﺧﺮى اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "إن اﻟﻐﺮض ﻣﻦ ﻫﺬا اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻫﻮ ﺗﺤﺴني اﻟﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ وﺗﻌﺰﻳﺰ اﻟﺤامﻳﺔ ﻣﻦ اﻧﺘﺸﺎر اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺑﺘﺤﺴني وﺗﻌﺰﻳﺰ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ ﺗﻮﺧﻴﺎً ﻟﺘﺤﻘﻴﻖ ﻧﻈﺎم ﻓﻌﺎل ﻳﺘﺴﻢ ﺑﺎﻟﻌﺪل واﻟﺸﻔﺎﻓﻴﺔ واﻹﻧﺼﺎف واﻟﻜﻔﺎءة واﳌﺴﺎواة ﻣﻦ أﺟﻞ ﻣﺎ ﻳﲇ: وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ H5N1 ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ )١( ﺑﴩﻳﺔ؛ اﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت وﺗﺒﺎدل اﻟﻔﻮاﺋﺪ اﻷﺧﺮى.",
      "extractCut": true
    },
    {
      "id": "sec-006-٤-اﻟﺘﻌﺎرﻳﻒ-واﳌﺼﻄﻠﺤﺎت",
      "number": null,
      "title": "٤– اﻟﺘﻌﺎرﻳﻒ واﳌﺼﻄﻠﺤﺎت",
      "level": 2,
      "pageStart": 14,
      "pageEnd": 16,
      "labelStart": "8",
      "labelEnd": "10",
      "words": 655,
      "summary": {
        "text": "Defines PIP biological materials, such as clinical specimens, wild-type virus isolates and candidate vaccine viruses made by WHO network laboratories, along with other technical terms like wild-type influenza viruses and genetic sequences.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻓريوس اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻓريوس أﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩﻳﺔ",
          "heading": false
        },
        {
          "term": "اﻟﻨﻤﻂ اﻟﱪي",
          "heading": false
        }
      ],
      "extract": ".ﻷﻏﺮاض ﻫﺬا اﻹﻃﺎر ﺗﻘﺼﺪ ﺑﺎﳌﺼﻄﻠﺤﺎت اﻟﺘﺎﻟﻴﺔ اﳌﻌﺎين اﻟﻮاردة أدﻧﺎه اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ٤–١ ﺗﺸﻤﻞ ﻋﺒﺎرة »اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ١«، ﻷﻏﺮاض ﻫﺬا اﻹﻃﺎر )واﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد اﻟﻮارد ﰲ اﳌﻠﺤﻖ واﻻﺧﺘﺼﺎﺻﺎت اﻟﻮاردة ﰲ اﳌﻠﺤﻖ( وآﻟﻴﺔ ﺗﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا، H5N1 اﻟﻌﻴﻨﺎت اﻟﴪﻳﺮﻳﺔ اﻟﺒﴩﻳﺔ،٢ وﻣﻌﺰوﻻت ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩﻳﺔ ﻣﻦ اﻟﻨﻤﻂ اﻟﱪي وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ",
      "extractCut": true
    },
    {
      "id": "sec-007-أﺳامء-اﳌﺆﺳﺴﺎت-واﳌﻨﻈامت-واﻟﻜﻴﺎﻧﺎت",
      "number": null,
      "title": "أﺳامء اﳌﺆﺳﺴﺎت واﳌﻨﻈامت واﻟﻜﻴﺎﻧﺎت",
      "level": 3,
      "pageStart": 16,
      "pageEnd": 18,
      "labelStart": "10",
      "labelEnd": "12",
      "words": 653,
      "summary": {
        "text": "Defines the institutions and entities named in the framework, including essential regulatory laboratories, influenza vaccine, diagnostic and pharmaceutical manufacturers, national influenza centres and WHO's PIP vaccine stockpile.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﻷﺧﺮى اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﺗﻌﻴﻨﻬﺎ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ وإﱃ",
          "heading": false
        }
      ],
      "extract": "٤–٣ »اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ« ﻫﻲ اﳌﺨﺘﱪات اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ ﺗﻌﻴﻨﻬﺎ اﳌﻨﻈﻤﺔ واﻟﺘﻲ ﻣﻘﺮﻫﺎ ﰲ اﻟﻮﻛﺎﻻت اﻟﺘﻨﻈﻴﻤﻴﺔ اﻟﻮﻃﻨﻴﺔ أو ﺗﻨﺘﺴﺐ إﻟﻴﻬﺎ، وﻟﻬﺎ دور ﺣﺎﺳﻢ ﻋﲆ اﳌﺴﺘﻮى اﻟﻌﺎﳌﻲ ﰲ اﺳﺘﺤﺪاث ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩﻳﺔ وﺗﻨﻈﻴﻤﻬﺎ وﺗﻮﺣﻴﺪﻫﺎ اﻟﻘﻴﺎﳼ. وﻫﺬه اﳌﺨﺘﱪات ﺗﺸﺎرك ﰲ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ وﻓﻘﺎً ﻻﺧﺘﺼﺎﺻﺎﺗﻬﺎ. »ﻣﻨﺘﺠﻮ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ووﺳﺎﺋﻞ ﺗﺸﺨﻴﺼﻬﺎ واﳌﺴﺘﺤﴬات اﻟﺼﻴﺪﻻﻧﻴﺔ اﳌﻀﺎدة ﻟﻬﺎ« ﻳُﻘﺼﺪ ﺑﻬﻢ اﻟﻜﻴﺎﻧﺎت اﻟﻌﻤﻮﻣﻴﺔ أو اﻟﺨﺎﺻﺔ مبﺎ ﻓﻴﻬﺎ اﳌﺆﺳﺴﺎت اﻷﻛﺎدميﻴﺔ أو",
      "extractCut": true
    },
    {
      "id": "sec-008-٥-ﻧﻈﺎم-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﻣﻦ-أﺟﻞ-ﺗﺒﺎدل-وﻓر",
      "number": null,
      "title": "٥– ﻧﻈﺎم اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﻦ أﺟﻞ ﺗﺒﺎدل وﻓريوﺳﺎت H5N1 ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ",
      "level": 2,
      "pageStart": 18,
      "pageEnd": 18,
      "labelStart": "12",
      "labelEnd": "12",
      "words": 13,
      "summary": {
        "text": "The heading for section 5 on the PIP system for sharing H5N1 and other potential pandemic influenza viruses.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "وﻓريوﺳﺎت H5N1 ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ",
      "extractCut": false
    },
    {
      "id": "sec-009-اﻷﺣﻜﺎم-اﻟﻌﺎﻣﺔ",
      "number": null,
      "title": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ",
      "level": 3,
      "pageStart": 18,
      "pageEnd": 20,
      "labelStart": "12",
      "labelEnd": "14",
      "words": 626,
      "summary": {
        "text": "Sets out the general provisions for virus sharing, under which Member States send PIP materials from human H5N1 and other potential pandemic cases to WHO collaborating centres or H5 reference laboratories and consent to onward transfer. It also covers genetic sequence data and the traceability mechanism, noting that its terminology has been changed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا واﳌﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ",
          "heading": false
        },
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ",
          "heading": false
        }
      ],
      "extract": "٥–١ ﻳﻨﺒﻐﻲ أن ﺗﻮرد اﻟﺪول اﻷﻋﻀﺎء، ﻋﻦ ﻃﺮﻳﻖ ﻣﺮاﻛﺰﻫﺎ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا وﻣﺨﺘﱪاﺗﻬﺎ اﻷﺧﺮى ٥–١–١ اﳌﺮﺧﺺ ﻟﻬﺎ، إﱃ اﳌﺮﻛﺰ اﳌﺘﻌﺎون ﻣﻊ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا أو اﳌﺨﺘﱪ اﳌﺮﺟﻌﻲ اﻟﺘﺎﺑﻊ ﻟﻠﻤﻨﻈﻤﺔ اﻟﺬي ﺗﺨﺘﺎره دوﻟﺔ اﳌﻨﺸﺄ اﻟﻌﻀﻮ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ H5 واﳌﻌﻨﻲ ﺑﺎﻟﻨﻤﻂ H5N1 ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، اﳌﺄﺧﻮذة ﻣﻦ ﺟﻤﻴﻊ ﺣﺎﻻت اﻹﺻﺎﺑﺔ ﺑﺎﻟﻔريوﺳﺎت ﻣﻦ اﻟﻨﻤﻂ وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ ﺗﻮرﻳﺪاً ﴎﻳﻌﺎً وﻣﻨﺘﻈامً وﻣﻮﻗﻮﺗﺎً ﺑﻘﺪر",
      "extractCut": true
    },
    {
      "id": "sec-010-ﺻﻴﻎ-اﻻﺗﻔﺎق-اﳌﻮﺣﺪ-ﻟﻨﻘﻞ-اﳌﻮاد",
      "number": null,
      "title": "ﺻﻴﻎ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد",
      "level": 3,
      "pageStart": 20,
      "pageEnd": 22,
      "labelStart": "14",
      "labelEnd": "16",
      "words": 301,
      "summary": {
        "text": "States that Standard Material Transfer Agreement 1 covers transfers within WHO's network and SMTA 2 covers transfers outside it. It then opens section 6 on benefit sharing, setting out its general provisions, such as surveillance, risk assessment and capacity building.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻨﻘﻞ اﳌﻮاد",
          "heading": true
        },
        {
          "term": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ",
          "heading": true
        },
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "ﺗﺒﺎدل ﻓﻮاﺋﺪ",
          "heading": false
        },
        {
          "term": "ﻓﻮاﺋﺪ اﻟﺘﺄﻫﺐ",
          "heading": false
        },
        {
          "term": "اﻟﺠﺎﺋﺤﺔ وﺗﻘﺪﻳﺮ",
          "heading": false
        },
        {
          "term": "ﻧﻈﺎم ﺗﺒﺎدل",
          "heading": false
        },
        {
          "term": "اﻟﺒﻠﺪان اﳌﺘﻠﻘﻴﺔ",
          "heading": false
        }
      ],
      "extract": "٥–٤ ﻳﺴﺘﻌﻤﻞ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ١، اﻟﻮارد ﰲ اﳌﻠﺤﻖ ١، ﻟﺘﻐﻄﻴﺔ ﺟﻤﻴﻊ ﻋﻤﻠﻴﺎت ﻧﻘﻞ اﳌﻮاد ٥–٤–١ اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﺎدام اﻻﺗﻔﺎق ﺳﺎرﻳﺎً. ﺑﻨﺎءً ﻋﲆ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ٢، اﻟﻮارد ﰲ اﳌﻠﺤﻖ ٢، ﻳﻌﻘﺪ اﳌﺪﻳﺮ اﻟﻌﺎم اﺗﻔﺎﻗﺎت ﻣﻊ ٥–٤–٢ ﻫﻴﺌﺎت ﻣﻦ ﺧﺎرج ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ. وﺳﺘﺸﻤﻞ ﻫﺬه اﻻﺗﻔﺎﻗﺎت ﺟﻤﻴﻊ ﻋﻤﻠﻴﺎت ﻧﻘﻞ اﳌﻮاد اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ إﱃ اﻟﺠﻬﺎت اﳌﺘﻠﻘﻴﺔ ﻣﺎداﻣﺖ ﻫﺬه اﻻﺗﻔﺎﻗﺎت ﺳﺎرﻳﺔ. ٦– ﻧﻈﺎم ﺗﺒﺎدل ﻓﻮاﺋﺪ",
      "extractCut": true
    },
    {
      "id": "sec-011-ﺗﻨﺴﻴﻖ-ﻣﻨﻈﻤﺔ-اﻟﺼﺤﺔ-اﻟﻌﺎﳌﻴﺔ-ﻟﻠﺘﺄﻫﺐ-واﻟﺘﺼﺪي-ﻟﻸﻧﻔﻠﻮﻧ",
      "number": null,
      "title": "ﺗﻨﺴﻴﻖ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﻠﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "level": 3,
      "pageStart": 22,
      "pageEnd": 24,
      "labelStart": "16",
      "labelEnd": "18",
      "words": 647,
      "summary": {
        "text": "Describes WHO coordination of pandemic preparedness and response under the International Health Regulations (2005), with fair allocation of scarce resources. It also covers pandemic risk assessment and the supply of candidate vaccine viruses, diagnostic reagents and test kits. Laboratory and surveillance capacity building in developing countries is also addressed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": true
        },
        {
          "term": "اﻟﺠﺎﺋﺤﺔ واﻟﺘﺼﺪي",
          "heading": true
        },
        {
          "term": "اﻟﺪول اﻷﻋﻀﺎء",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا واﳌﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ ﺑﺸﺄن",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        }
      ],
      "extract": "٦–١ ﺳﺘﻨﺴﻖ اﳌﻨﻈﻤﺔ أﻧﺸﻄﺔ اﻟﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﺠﻮاﺋﺢ اﻷﻧﻔﻠﻮﻧﺰا ﻃﺒﻘﺎً ﻟﻸﺣﻜﺎم اﳌﻨﻄﺒﻘﺔ اﻟﻮاردة ﰲ اﻟﻠﻮاﺋﺢ اﻟﺼﺤﻴﺔ اﻟﺪوﻟﻴﺔ )٥٠٠٢( وﰲ ﻫﺬا اﻹﻃﺎر. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻟﻔﻮاﺋﺪ اﳌﻮﺟﺰة ﰲ ﻫﺬا اﻹﻃﺎر ﻳﻨﺒﻐﻲ ﻟﻠﻤﻨﻈﻤﺔ أن ﺗﻮﱄ اﻫﺘامﻣﺎً ﺧﺎﺻﺎً ﻟﻠﺴﻴﺎﺳﺎت واﳌامرﺳﺎت اﻟﺘﻲ ﺗﻌﺰز ﺗﺨﺼﻴﺺ اﳌﻮارد اﻟﻄﺒﻴﺔ اﻟﺸﺤﻴﺤﺔ ﺑﻄﺮﻳﻘﺔ ﻋﺎدﻟﺔ وﻣﻨﺼﻔﺔ وﺷﻔﺎﻓﺔ )مبﺎ ﻓﻴﻬﺎ ﻋﲆ ﺳﺒﻴﻞ اﳌﺜﺎل ﻻ اﻟﺤﴫ اﻟﻠﻘﺎﺣﺎت وﻣﻀﺎدات اﻟﻔريوﺳﺎت وﻣﻮاد اﻟﺘﺸﺨﻴﺺ( ﻃﻮال اﻟﺠﻮاﺋﺢ، وذﻟﻚ ﺑﻨﺎءً ﻋﲆ اﳌﺨﺎﻃﺮ واﺣﺘﻴﺎﺟﺎت اﻟﺼﺤﺔ",
      "extractCut": true
    },
    {
      "id": "sec-012-ﺑﻨﺎء-اﻟﻘﺪرات-اﻟﺘﻨﻈﻴﻤﻴﺔ",
      "number": null,
      "title": "ﺑﻨﺎء اﻟﻘﺪرات اﻟﺘﻨﻈﻴﻤﻴﺔ",
      "level": 3,
      "pageStart": 24,
      "pageEnd": 26,
      "labelStart": "18",
      "labelEnd": "20",
      "words": 576,
      "summary": {
        "text": "Covers regulatory capacity building for rapid approval of influenza products, national antiviral stockpiles and the WHO stockpile of PIP vaccines, including deployment plans and use in affected countries before a pandemic.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ اﻻﺣﺘﻴﺎﻃﻲ",
          "heading": false
        },
        {
          "term": "اﳌﺪﻳﺮ اﻟﻌﺎم",
          "heading": false
        },
        {
          "term": "ﻣﺨﺰون اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﳌﺨﺰون اﻻﺣﺘﻴﺎﻃﻲ",
          "heading": false
        },
        {
          "term": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻟﺘﺄﻫﺐ",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت ﻓريوﺳﺎت",
          "heading": false
        }
      ],
      "extract": "٦–٧ ﻳﻨﺒﻐﻲ ﻟﻠﺪول اﻷﻋﻀﺎء ذات اﻟﻘﺪرة اﻟﺘﻨﻈﻴﻤﻴﺔ اﳌﺘﻄﻮرة أن ﺗﺤﺴﻦ وﺗﻌﺰز، ﻋﻨﺪ اﻟﻄﻠﺐ، ٦–٧–١ اﻟﻌﻤﻞ اﻟﺬي ﺗﻀﻄﻠﻊ ﺑﻪ اﻟﺪول اﻷﻋﻀﺎء ﻣﻊ اﳌﻨﻈﻤﺔ، وﻻﺳﻴام اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ، ﻟﺘﻌﺰﻳﺰ ﻗﺪرة اﻟﺴﻠﻄﺎت اﻟﺘﻨﻈﻴﻤﻴﺔ ﻋﲆ اﺗﺨﺎذ اﻟﺘﺪاﺑري اﻟﻼزﻣﺔ ﻟﻠﻤﻮاﻓﻘﺔ اﻟﴪﻳﻌﺔ ﻋﲆ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ووﺳﺎﺋﻞ ﺗﺸﺨﻴﺺ اﻷﻧﻔﻠﻮﻧﺰا واﳌﺴﺘﺤﴬات اﻟﺼﻴﺪﻻﻧﻴﺔ اﳌﻀﺎدة ﻟﻬﺎ اﳌﺄﻣﻮﻧﺔ واﻟﻨﺎﺟﻌﺔ، مبﺎ ﰲ ذﻟﻚ ﺗﻠﻚ اﻟﺘﻲ ﺗُﺴﺘﺤﺪث ﻣﻦ اﺳﺘﻌامل اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، وﻻﺳﻴام ﻣﺎ ﻳﺘﻢ",
      "extractCut": true
    },
    {
      "id": "sec-013-٦٠١-إﺗﺎﺣﺔ-اﻟﻠﻘﺎﺣﺎت-ﰲ-اﻟﻔﱰة-اﻟﻔﺎﺻﻠﺔ-ﺑني-أي-ﺟﺎﺋﺤﺘن",
      "number": null,
      "title": "٦–٠١ إﺗﺎﺣﺔ اﻟﻠﻘﺎﺣﺎت ﰲ اﻟﻔﱰة اﻟﻔﺎﺻﻠﺔ ﺑني أي ﺟﺎﺋﺤﺘني ﰲ اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ",
      "level": 3,
      "pageStart": 26,
      "pageEnd": 29,
      "labelStart": "20",
      "labelEnd": "23",
      "words": 975,
      "summary": {
        "text": "Describes measures to improve access to pandemic influenza vaccines in developing countries between and during pandemics, including reserving part of production, tiered pricing based on country income and technology transfer. It sets out the annual partnership contribution from manufacturers, benchmarked at half the estimated US$56.6 million running cost of the WHO network in 2010.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ",
          "heading": true
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺪول اﻷﻋﻀﺎء",
          "heading": false
        },
        {
          "term": "ﻣﻨﺘﺠﻲ ﻟﻘﺎﺣﺎت",
          "heading": false
        },
        {
          "term": "اﻷﻋﻀﺎء اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "اﳌﺪﻳﺮ اﻟﻌﺎم",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا ووﺳﺎﺋﻞ",
          "heading": false
        }
      ],
      "extract": "ﺑﴫف اﻟﻨﻈﺮ ﻋﻦ اﻟﺘﺪاﺑري اﻟﺮاﻣﻴﺔ إﱃ دﻋﻢ ﻣﺨﺰون اﳌﻨﻈﻤﺔ اﻻﺣﺘﻴﺎﻃﻲ ﻣﻦ ﻟﻘﺎﺣﺎت اﻟﺘﺄﻫﺐ ٦–٠١–١ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﺒﻴﻨﺔ ﰲ اﻟﻔﺮع ٦–٩ أﻋﻼه ﻳﻨﺒﻐﻲ ﻟﻠﺪول اﻷﻋﻀﺎء: أن ﺗﺤﺚ ﻣﻨﺘﺠﻲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻋﲆ أن ﻳﻘﺘﻄﻌﻮا ﺟﺰءاً ﻣﻦ ﻛﻞ دورة ﻹﻧﺘﺎج ﻟﻘﺎﺣﺎت )١( وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ وﻳﺨﺼﺼﻮه H5N1 اﻟﻔريوس ﻟﻠﺨﺰن و/ أو ﻟﻼﺳﺘﻌامل ﻣﻦ ﻗِﺒَﻞ اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ؛ أن ﺗﻮاﺻﻞ اﻟﻌﻤﻞ ﻣﻊ ﺑﻌﻀﻬﺎ وﻣﻊ اﳌﺪﻳﺮ اﻟﻌﺎم وﻣﻨﺘﺠﻲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻋﲆ ﺗﺄﻣني ﻛﻤﻴﺎت",
      "extractCut": true
    },
    {
      "id": "sec-014-٧-ﺗﴫﻳﻒ-اﻟﺸﺆون-واﻻﺳﺘﻌﺮاض",
      "number": null,
      "title": "٧– ﺗﴫﻳﻒ اﻟﺸﺆون، واﻻﺳﺘﻌﺮاض",
      "level": 2,
      "pageStart": 29,
      "pageEnd": 31,
      "labelStart": "23",
      "labelEnd": "25",
      "words": 638,
      "summary": {
        "text": "Sets out governance of the framework, with oversight by the World Health Assembly and an independent Advisory Group of international experts. It also describes how the Director-General reviews breaches of terms of reference or transfer agreements and may suspend or revoke a laboratory's WHO designation.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري",
          "heading": false
        },
        {
          "term": "اﳌﺪﻳﺮ اﻟﻌﺎم",
          "heading": false
        },
        {
          "term": "ﻫﺬا اﻹﻃﺎر",
          "heading": false
        },
        {
          "term": "ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ",
          "heading": false
        },
        {
          "term": "ﺗﻨﻔﻴﺬ ﻫﺬا",
          "heading": false
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ ﺑﺸﺄن",
          "heading": false
        },
        {
          "term": "واﳌﺪﻳﺮ اﻟﻌﺎم",
          "heading": false
        }
      ],
      "extract": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ ٧–١ ﺗﺘﻮﱃ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ اﻹﴍاف ﻋﲆ ﺗﻨﻔﻴﺬ ﻫﺬا اﻹﻃﺎر مبﺸﻮرة ﻣﻦ اﳌﺪﻳﺮ اﻟﻌﺎم. ٧–١–١ ﺗﻨﺸﺄ مبﻮﺟﺐ ﻫﺬه اﻟﻮﺛﻴﻘﺔ آﻟﻴﺔ ﻟﻠﻤﺮاﻗﺒﺔ ﺗﻀﻢ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﺪﻳﺮ اﻟﻌﺎم ٧–١–٢ و»اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري« اﳌﺴﺘﻘﻞ اﳌﻨﺸﺄ ﰲ إﻃﺎر اﻟﺒﻴﺎن اﳌﺒﺪيئ اﻟﺼﺎدر ﰲ ﺗﴩﻳﻦ اﻟﺜﺎين/ ﻧﻮﻓﻤﱪ ٧٠٠٢ واﳌﺆﻟﻒ ﻣﻦ ﺧﱪاء دوﻟﻴني ﻳﺨﺪﻣﻮن اﳌﻨﻈﻤﺔ ﺑﺸﻜﻞ ﺣﴫي. وﺗﺮد أدﻧﺎه وﻇﺎﺋﻒ ﻛﻞ ﻣﻦ ﻫﺆﻻء: ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻫﻲ اﻟﺘﻲ ﺗﺘﻮﱃ ﺗﻨﻔﻴﺬ ﻫﺬا اﻹﻃﺎر وذﻟﻚ وﻓﻘﺎً ﳌﻬﻤﺘﻬﺎ )١( اﻟﺪﺳﺘﻮرﻳﺔ",
      "extractCut": true
    },
    {
      "id": "sec-015-رﺻﺪ-واﺳﺘﻌﺮاض-اﻹﻃﺎر",
      "number": null,
      "title": "رﺻﺪ واﺳﺘﻌﺮاض اﻹﻃﺎر",
      "level": 3,
      "pageStart": 31,
      "pageEnd": 33,
      "labelStart": "25",
      "labelEnd": "147",
      "words": 125,
      "summary": {
        "text": "Requires the Director-General to report to the World Health Assembly every two years on laboratory capacity, vaccine production capacity, benefit sharing and contributions, and schedules a review of the framework by 2016.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻫﺬا اﻹﻃﺎر",
          "heading": false
        },
        {
          "term": "اﳌﺠﻠﺲ اﻟﺘﻨﻔﻴﺬي",
          "heading": false
        },
        {
          "term": "ﻃﺮﻳﻖ اﳌﺠﻠﺲ",
          "heading": false
        },
        {
          "term": "ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        }
      ],
      "extract": "٧–٤ ﻳﻘﺪم اﳌﺪﻳﺮ اﻟﻌﺎم، ﺑﺎﻟﺘﺸﺎور ﻣﻊ اﻟﺪول اﻷﻋﻀﺎء واﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري، إﱃ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻋﻦ ٧–٤–١ ﻃﺮﻳﻖ اﳌﺠﻠﺲ اﻟﺘﻨﻔﻴﺬي ﺗﻘﺮﻳﺮاً ﻛﻞ ﻋﺎﻣني ﻋﻦ اﻟﺤﺎﻟﺔ واﻟﺘﻘﺪم اﳌﺤﺮز ﺑﺸﺄن ﻣﺎ ﻳﲇ: ﻗﺪرات اﳌﺨﺘﱪات واﻟﱰﺻﺪ )اﻟﻔﺮع ٦–٦ ﻣﻦ ﻫﺬا اﻹﻃﺎر( )١( ﻗﺪرات إﻧﺘﺎج ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﰲ اﻟﻌﺎمل )اﻧﻈﺮ اﻟﻔﺮﻋني ٦–٣١–١ و٦–٣١–٢ ﻣﻦ ﻫﺬا )٢( اﻹﻃﺎر( ﺣﺎﻟﺔ اﻻﺗﻔﺎﻗﺎت اﳌﻌﻘﻮدة ﻣﻊ دواﺋﺮ اﻟﺼﻨﺎﻋﺔ، وﻻﺳﻴام اﳌﻌﻠﻮﻣﺎت اﳌﺘﻮﻓﺮة ﻋﻦ اﻟﻠﻘﺎﺣﺎت )٣( وﻣﻀﺎدات اﻟﻔريوﺳﺎت وﺳﺎﺋﺮ اﳌﻮاد",
      "extractCut": true
    },
    {
      "id": "sec-016-اﳌـﻼﺣــﻖ",
      "number": null,
      "title": "اﳌـﻼﺣــﻖ",
      "level": 1,
      "pageStart": 33,
      "pageEnd": 35,
      "labelStart": "147",
      "labelEnd": "29",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-017-اﳌﻠﺤﻖ-١",
      "number": null,
      "title": "اﳌﻠﺤﻖ ١",
      "level": 2,
      "pageStart": 35,
      "pageEnd": 37,
      "labelStart": "29",
      "labelEnd": "31",
      "words": 595,
      "summary": {
        "text": "Annex 1, Standard Material Transfer Agreement 1 for transfers within WHO's global influenza surveillance network, setting out the parties, the materials covered and obligations such as involving and acknowledging scientists from originating countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻫﺬا اﻻﺗﻔﺎق",
          "heading": false
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﻻﺗﻔﺎق رﻗﻢ",
          "heading": false
        },
        {
          "term": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ",
          "heading": false
        },
        {
          "term": "داﺧﻞ ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻮاد ﻃﺒﻘﺎ",
          "heading": false
        },
        {
          "term": "ﻟﻨﻘﻞ اﳌﻮاد",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ وﻃﺒﻘﺎ",
          "heading": false
        }
      ],
      "extract": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ١ داﺧﻞ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﺗﻌﺰﻳﺰاً ﻟﻺﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺑﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى )»اﻹﻃﺎر«( أﻋﺪ ﻫﺬا اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد )»اﻻﺗﻔﺎق« أو »اﻻﺗﻔﺎق رﻗﻢ ١«(. اﳌﺎدة ١– اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق ،اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻫام ﺣﴫاً ﻣﻦ ﻣﺨﺘﱪات اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ ﻋﻴﻨﺘﻬﺎ اﳌﻨﻈﻤﺔ أو اﻋﱰﻓﺖ ﺑﻬﺎ ١–١ وﻗﺒﻠﺖ ﻫﺬه",
      "extractCut": true
    },
    {
      "id": "sec-018-اﳌﺎدة-٦-ﺣﻘﻮق-اﳌﻠﻜﻴﺔ-اﻟﻔﻜﺮﻳﺔ",
      "number": null,
      "title": "اﳌﺎدة ٦– ﺣﻘﻮق اﳌﻠﻜﻴﺔ اﻟﻔﻜﺮﻳﺔ",
      "level": 3,
      "pageStart": 37,
      "pageEnd": 39,
      "labelStart": "31",
      "labelEnd": "33",
      "words": 450,
      "summary": {
        "text": "Articles of SMTA 1 stating that neither party may seek intellectual property rights on the materials, with terms on prior rights, dispute settlement, suspension or withdrawal and acceptance without a printed signature.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﳌﺎدة",
          "heading": true
        },
        {
          "term": "ﻫﺬا اﻻﺗﻔﺎق",
          "heading": false
        },
        {
          "term": "اﻻﺗﻔﺎق رﻗﻢ",
          "heading": false
        },
        {
          "term": "اﳌﻮرد واﳌﺘﻠﻘﻲ",
          "heading": false
        },
        {
          "term": "ﻳﻘﺪم اﳌﻮرد",
          "heading": false
        },
        {
          "term": "ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        },
        {
          "term": "اﻟﻌﺎﳌﻴﺔ اﻹﻃﺎر",
          "heading": false
        }
      ],
      "extract": ".ﻻ ﻳﺤﻖ ﻟﻠﻤﻮرد واﳌﺘﻠﻘﻲ اﻟﺘامس أي ﺣﻘﻮق ﻣﻠﻜﻴﺔ ﻓﻜﺮﻳﺔ ﺑﺨﺼﻮص اﳌﻮاد ٦–١ ﻳﻘﺮ اﳌﻮرد واﳌﺘﻠﻘﻲ ﺑﺄن ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻻ ﻣﺴﺎس ﻓﻴﻪ ﺑﺄي ﺣﻘﻮق ﻣﻠﻜﻴﺔ ﻓﻜﺮﻳﺔ ﺑﺨﺼﻮص اﳌﻮاد اﻟﺘﻲ ٦–٢ ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ ﻗﺒﻞ ﺗﺎرﻳﺦ اﻋﺘامد اﻹﻃﺎر ﰲ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ. ﻳﺠﻮز أن ﻳﻜﻮن اﳌﻮرد اﳌﻨﺼﻮص ﻋﻠﻴﻪ ﰲ ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻗﺪ اﺳﺘﻌﻤﻞ ﺗﻜﻨﻮﻟﻮﺟﻴﺎ ﻣﺤﻤﻴﺔ ﺑﺤﻘﻮق ٦–٣ اﳌﻠﻜﻴﺔ اﻟﻔﻜﺮﻳﺔ ﻹﻧﺘﺎج اﳌﻮاد و/ أو ﺗﺤﻮﻳﺮﻫﺎ. ﻓﻴﻘﺮ ﻣﺘﻠﻘﻲ ﻫﺬه اﳌﻮاد ﺑﺎﺣﱰام ﻫﺬه اﻟﺤﻘﻮق. اﳌﺎدة ٧– ﻓﺾ اﻟﻨﺰاﻋﺎت ﻋﻨﺪﻣﺎ ﻳﻨﺸﺄ",
      "extractCut": true
    },
    {
      "id": "sec-019-اﳌﻠﺤﻖ-٢",
      "number": null,
      "title": "اﳌﻠﺤﻖ ٢",
      "level": 2,
      "pageStart": 39,
      "pageEnd": 41,
      "labelStart": "33",
      "labelEnd": "35",
      "words": 759,
      "summary": {
        "text": "Annex 2, Standard Material Transfer Agreement 2 between WHO and recipients outside its network, setting out the parties, materials and the recipient's commitments, including onward sharing only with other SMTA holders.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "ﻟﻨﻘﻞ اﳌﻮاد",
          "heading": false
        },
        {
          "term": "ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﺘﺸﺨﻴﺺ اﻟﴬورﻳﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻨﻈﻤﺔ ﺑﺄﺳﻌﺎر",
          "heading": false
        },
        {
          "term": "اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ",
          "heading": false
        },
        {
          "term": "واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد ٢ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ٢ ﺧﺎرج اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ اﳌﺎدة ١– اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﺘﻠﻘﻲ.١ اﳌﺎدة ٢– ﻣﻮﺿﻮع ﻫﺬا اﻻﺗﻔﺎق ﺗﺨﻀﻊ ﻷﺣﻜﺎم ﻫﺬا اﻻﺗﻔﺎق اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، ﺣﺴﺐ ﺗﻌﺮﻳﻔﻬﺎ ﰲ اﻟﻔﺮع ٤–١ ﻣﻦ اﻹﻃﺎر )وﺗﺪﻋﻰ ﻓﻴام ﺑﻌﺪ »اﳌﻮاد«(، اﳌﻨﻘﻮﻟﺔ إﱃ اﳌﺘﻠﻘﻲ. اﳌﺎدة ٢ ﻣﻜﺮر– اﻟﺘﻌﺎرﻳﻒ ﺣﺴﺒام وردت ﰲ اﻟﻔﺮع ٤ ﻣﻦ",
      "extractCut": true
    },
    {
      "id": "sec-020-اﳌﺎدة-٥-ﻓﺾ-اﻟﻨﺰاﻋﺎت",
      "number": null,
      "title": "اﳌﺎدة ٥– ﻓﺾ اﻟﻨﺰاﻋﺎت",
      "level": 3,
      "pageStart": 41,
      "pageEnd": 43,
      "labelStart": "35",
      "labelEnd": "37",
      "words": 193,
      "summary": {
        "text": "Further articles of SMTA 2 on dispute settlement by binding arbitration, WHO's privileges and immunities, and signature, with several terms left for the parties to agree.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻟﻄﺮﻓﺎن اﳌﺎدة",
          "heading": false
        },
        {
          "term": "ﻋﻠﻴﻬﺎ اﻟﻄﺮﻓﺎن",
          "heading": false
        },
        {
          "term": "ﻳﺘﻔﻖ ﻋﻠﻴﻬﺎ",
          "heading": false
        },
        {
          "term": "ﻫﺬا اﻻﺗﻔﺎق",
          "heading": false
        },
        {
          "term": "اﻟﺘﻮﻗﻴﻊ",
          "heading": false
        },
        {
          "term": "ﺑﺎﻟﻨﻴﺎﺑﺔ",
          "heading": false
        },
        {
          "term": "اﳌﻠﺤﻖ",
          "heading": false
        },
        {
          "term": "ﺣﺴﺐ",
          "heading": false
        }
      ],
      "extract": "ﻋﻨﺪﻣﺎ ﻳﺘﻌﺬر ﺣﻞ أي ﻧﺰاع ﺑﺎﳌﻔﺎوﺿﺎت أو ﺑﺄي وﺳﺎﺋﻞ أﺧﺮى ﻏري ﻣﻠﺰﻣﺔ ﻳﺮﺗﻀﻴﻬﺎ اﻟﻄﺮﻓﺎن، ﻳﻌﺮض اﻟﻨﺰاع ﻋﲆ اﻟﺘﺤﻜﻴﻢ ﺑﺎﻟﴩوط اﻟﺘﻲ ﻳﺮﺗﻀﻴﻬﺎ اﻟﻄﺮﻓﺎن وﺗﺼﺒﺢ ﻗﺮارات اﻟﺘﺤﻜﻴﻢ ﻣﻠﺰﻣﺔ. اﳌﺎدة ٦– اﳌﺴﺆوﻟﻴﺔ واﻟﺘﻌﻮﻳﺾ .ﻳﺘﻔﻖ ﻋﻠﻴﻬام اﻟﻄﺮﻓﺎن اﳌﺎدة ٧– اﻻﻣﺘﻴﺎزات واﻟﺤﺼﺎﻧﺎت ﻻ ﻳﻮﺟﺪ ﰲ ﻫﺬه اﻟﴩوط وﻻ ﰲ ﻣﺎ ﻳﺘﻌﻠﻖ ﺑﻬﺎ ﻣﺎ ﻳﻠﺰم اﳌﻨﻈﻤﺔ ﺑﺎﻟﺨﻀﻮع ﻷي ﺗﴩﻳﻊ وﻃﻨﻲ أو وﻻﻳﺔ ﻗﺎﻧﻮﻧﻴﺔ وﻃﻨﻴﺔ، وﻻ ﻣﺎ ﻳﻌﺘﱪ ﺗﻨﺎزﻻً ﻋﻦ أي ﻣﻦ اﻣﺘﻴﺎزاﺗﻬﺎ وﺣﺼﺎﻧﺎﺗﻬﺎ اﳌﻨﺼﻮص ﻋﻠﻴﻬﺎ ﰲ »اﺗﻔﺎﻗﻴﺔ اﻣﺘﻴﺎزات اﻟﻮﻛﺎﻻت",
      "extractCut": true
    },
    {
      "id": "sec-021-اﳌﻠﺤﻖ-٣",
      "number": null,
      "title": "اﳌﻠﺤﻖ ٣",
      "level": 2,
      "pageStart": 43,
      "pageEnd": 45,
      "labelStart": "37",
      "labelEnd": "39",
      "words": 532,
      "summary": {
        "text": "Annex 3, the terms of reference of the PIP Advisory Group, setting out its functions of monitoring the framework and advising on topics such as stockpiles, surveillance, the traceability mechanism and use of contributions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﺴﺎﻫامت اﳌﺎﻟﻴﺔ",
          "heading": false
        },
        {
          "term": "ﻫﺬا اﻹﻃﺎر",
          "heading": false
        },
        {
          "term": "ﻓريوس اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﻫﺬا اﻟﻨﻈﺎم",
          "heading": false
        },
        {
          "term": "اﳌﺎﻟﻴﺔ وﻏري",
          "heading": false
        }
      ],
      "extract": "اﺧﺘﺼﺎﺻﺎت اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري )أﻗﺮﻫﺎ اﻻﺟﺘامع اﻟﺤﻜﻮﻣﻲ اﻟﺪوﱄ ﰲ دورﺗﻪ اﳌﺴﺘﺄﻧﻔﺔ اﳌﻌﻘﻮدة ﰲ ﻛﺎﻧﻮن اﻷول/ دﻳﺴﻤﱪ ٨٠٠٢ ﺑﺎﻟﺼﻴﻐﺔ اﻟﺘﻲ ﻋﺪﻟﻬﺎ ﺑﻬﺎ ﰲ ﻧﻴﺴﺎن/ أﺑﺮﻳﻞ ١١٠٢ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء واﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ ﻋﲆ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى(. ١– اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ووﻻﻳﺔ اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري دﻋﺎ اﻟﺒﻴﺎن اﳌﺆﻗﺖ اﻟﺬي اﻋﺘﻤﺪﺗﻪ اﻟﺪول اﻷﻋﻀﺎء ﰲ اﳌﻨﻈﻤﺔ اﻟﺘﻲ ﺷﺎرﻛﺖ ﰲ دورة اﻻﺟﺘامع ١–١ اﻟﺤﻜﻮﻣﻲ",
      "extractCut": true
    },
    {
      "id": "sec-022-٣-ﺗﻌﻴني-اﻷﻋﻀﺎء",
      "number": null,
      "title": "٣– ﺗﻌﻴني اﻷﻋﻀﺎء",
      "level": 3,
      "pageStart": 45,
      "pageEnd": 48,
      "labelStart": "39",
      "labelEnd": "42",
      "words": 731,
      "summary": {
        "text": "Describes how the 18-member Advisory Group is formed from three Member States per WHO region and how it operates, including meetings, reporting and conflicts of interest. A further section lists commitments on sharing genetic sequence data and acknowledging laboratories that supply PIP materials.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻣﺨﺘﱪات ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "ﻷﻗﺎﻟﻴﻢ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري",
          "heading": false
        },
        {
          "term": "ﺗﻘﺪم ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﻋﻤﻞ اﻟﻔﺮﻳﻖ",
          "heading": false
        },
        {
          "term": "ﻟﻨﻘﻞ اﳌﻮاد",
          "heading": false
        },
        {
          "term": "اﳌﻮﺣﺪ ﻟﻨﻘﻞ",
          "heading": false
        }
      ],
      "extract": "ﺳﻴﺘﺄﻟﻒ اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري ﻣﻦ ٨١ ﻋﻀﻮاً ﻳﻨﺘﻤﻮن إﱃ ﺛﻼث دول أﻋﻀﺎء ﻣﻦ ﻛﻞ إﻗﻠﻴﻢ ﻣﻦ أﻗﺎﻟﻴﻢ اﳌﻨﻈﻤﺔ ٣–١ وﻳﺘﺤﻠﻮن مبﺠﻤﻮﻋﺔ ﻣﺘﻨﻮﻋﺔ ﻣﻦ اﳌﻬﺎرات اﳌﻌﱰف ﺑﻬﺎ ﻋﲆ اﻟﺼﻌﻴﺪ اﻟﺪوﱄ ﰲ ﻣﺠﺎل رﺳﻢ اﻟﺴﻴﺎﺳﺎت وﻣﻦ ﺧﱪاء اﻟﺼﺤﺔ اﻟﻌﻤﻮﻣﻴﺔ واﻟﺨﱪاء اﻟﺘﻘﻨﻴني ﰲ ﻣﺠﺎل اﻷﻧﻔﻠﻮﻧﺰا. وﻳﻌﻤﻞ اﻷﻋﻀﺎء، ﰲ ﻣامرﺳﺘﻬﻢ ﳌﻬﺎﻣﻬﻢ، ﺑﻮﺻﻔﻬﻢ ﺧﱪاء دوﻟﻴني ﻳﺨﺪﻣﻮن ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ وﺣﺪﻫﺎ. ﻳﻌﻤﻞ ﻛﻞ ﻋﻀﻮ ﻟﺜﻼث ﺳﻨﻮات. وﺗﺴﺘﻐﺮق ﻣﺪة ﺗﻌﻴني ﻛﻞ ﻋﻀﻮ ﺛﻼث ﺳﻨﻮات ﻣﻊ ﺗﺠﺪﻳﺪ ﺗﻌﻴني ﺛُﻠﺚ ٣–٢ اﻷﻋﻀﺎء ﰲ ﻛﻞ ﻋﺎم؛",
      "extractCut": true
    },
    {
      "id": "sec-023-اﳌﻠﺤﻖ-٥",
      "number": null,
      "title": "اﳌﻠﺤﻖ ٥",
      "level": 2,
      "pageStart": 48,
      "pageEnd": 50,
      "labelStart": "42",
      "labelEnd": "44",
      "words": 741,
      "summary": {
        "text": "Annex 5, terms of reference for WHO collaborating centres for influenza when handling PIP materials, describing the global surveillance network and their duties on sharing materials and sequence data.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻣﺨﺘﱪات ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "اﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ",
          "heading": false
        },
        {
          "term": "ﺗﻘﺪم ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "ﺗﺘﺒﺎدل ﻣﺨﺘﱪات",
          "heading": false
        }
      ],
      "extract": "اﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ إﱃ ﻇﻬﻮر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ ذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ",
      "extractCut": true
    },
    {
      "id": "sec-024-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "level": 3,
      "pageStart": 50,
      "pageEnd": 55,
      "labelStart": "44",
      "labelEnd": "49",
      "words": 1321,
      "summary": {
        "text": "Sets out the core terms of reference for WHO collaborating centres for influenza, covering coordination with the WHO global influenza programme, virus characterisation, candidate vaccine development, training and support to national centres. It also requires them to acknowledge contributors in publications according to editorial guidelines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "اﳌﺒﺪءان اﻟﺘﻮﺟﻴﻬﻴﺎن",
          "heading": false
        },
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﳌﺮﺷﺤﺔ",
          "heading": false
        },
        {
          "term": "اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ",
          "heading": false
        },
        {
          "term": "ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﻔريوﺳﺎت اﻟﺘﻲ",
          "heading": false
        }
      ],
      "extract": ":اﳌﺮاﻛﺰ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ ﻫﻲ ﻣﺮاﻛﺰ اﻣﺘﻴﺎز ﺗﻌﻴﻨﻬﺎ اﳌﻨﻈﻤﺔ وﺗﻔﻲ مبﺎ ﻳﲇ أﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ اﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ ١– )اﳌﺒﺪءان اﻟﺘﻮﺟﻴﻬﻴﺎن ٢ و٧(؛ أداء اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ واﻻﺧﺘﺼﺎﺻﺎت اﻟﻨﻮﻋﻴﺔ ﺑﺎﻻﺳﺘﻌﺎﻧﺔ ﺑﺎﻟﺪﻋﻢ اﳌﺎﱄ اﻟﺬي ﺗﻮﻓﺮه اﳌﺼﺎدر ٢– اﻟﺤﻜﻮﻣﻴﺔ ﻓﻘﻂ و/ أو أي ﻣﺼﺎدر أﺧﺮى ﻏري ﺗﺠﺎرﻳﺔ؛ اﺳﺘﻌامل آﻟﻴﺔ اﳌﻨﻈﻤﺔ ﻟﺘﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻟﺘﺴﺠﻴﻞ",
      "extractCut": true
    },
    {
      "id": "sec-025-اﳌﺮاﻛﺰ-اﻟﻮﻃﻨﻴﺔ-اﳌﻌﻨﻴﺔ-ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
      "number": null,
      "title": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
      "level": 3,
      "pageStart": 55,
      "pageEnd": 57,
      "labelStart": "49",
      "labelEnd": "51",
      "words": 665,
      "summary": {
        "text": "Terms of reference for national influenza centres in handling PIP biological materials, including sending samples to WHO laboratories and sharing sequence data.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
          "heading": true
        },
        {
          "term": "اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ",
          "heading": true
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻣﺨﺘﱪات ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ",
          "heading": true
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "ﺗﻘﺪم ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ إﱃ ﻇﻬﻮر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ ذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ",
      "extractCut": true
    },
    {
      "id": "sec-026-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "level": 4,
      "pageStart": 57,
      "pageEnd": 59,
      "labelStart": "51",
      "labelEnd": "53",
      "words": 567,
      "summary": {
        "text": "Sets out the core terms of reference for national influenza centres, designated by health ministries and recognised by WHO, covering virus collection, testing, reporting and acknowledging contributors in publications.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ",
          "heading": false
        },
        {
          "term": "اﻟﻌﻴﻨﺎت اﻟﴪﻳﺮﻳﺔ",
          "heading": false
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺘﻲ ميﻜﻦ",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "ﺗﺮﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا ﻫﻲ ﻣﺨﺘﱪات ﺗﺴﺘﻮﰲ اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﳌﺬﻛﻮرة أدﻧﺎه. واﳌﺮﻛﺰ اﻟﻮﻃﻨﻲ اﳌﻌﻨﻲ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا ﻫﻮ اﳌﺮﻛﺰ اﻟﺬي ﺗﻌﻴﻨﻪ وزارة اﻟﺼﺤﺔ ﰲ اﻟﺒﻠﺪ اﳌﻌﻨﻲ وﺗﻌﱰف ﺑﻪ اﳌﻨﻈﻤﺔ. وﻳﺠﻮز أن ﺗﻜﻮن ﻟﻠﻤﺮﻛﺰ اﻟﻮﻃﻨﻲ اﳌﻌﻨﻲ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﺰاﻣﺎت إﺿﺎﻓﻴﺔ مبﻮﺟﺐ ﺳﻠﻄﺔ وزارة اﻟﺼﺤﺔ اﻟﺘﺎﺑﻊ ﻟﻬﺎ. أﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ اﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ ١– )اﳌﺒﺪءان اﻟﺘﻮﺟﻴﻬﻴﺎن ٢ و٧(؛",
      "extractCut": true
    },
    {
      "id": "sec-027-h5-اﳌﺨﺘﱪات-اﳌﺮﺟﻌﻴﺔ-اﻟﺘﺎﺑﻌﺔ-ﻟﻠﻤﻨﻈﻤﺔ-واﳌﻌﻨﻴﺔ-ﺑﺎﻟﻨﻤ",
      "number": null,
      "title": "H5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ",
      "level": 3,
      "pageStart": 59,
      "pageEnd": 59,
      "labelStart": "53",
      "labelEnd": "53",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-028-اﻻﺧﺘﺼﺎﺻﺎت-اﳌﺘﻌﻠﻘﺔ-ﺑﺎﻟﺘﻌﺎﻣﻞ-ﻣﻊ-اﳌﻮاد-اﻟﺒﻴﻮﻟﻮﺟﻴﺔ-ا",
      "number": null,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "level": 4,
      "pageStart": 59,
      "pageEnd": 61,
      "labelStart": "53",
      "labelEnd": "55",
      "words": 678,
      "summary": {
        "text": "Terms of reference for WHO H5 reference laboratories in handling PIP biological materials, repeating the network description and duties on sharing materials and sequence data.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ",
          "heading": true
        },
        {
          "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": true
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻣﺨﺘﱪات ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ",
          "heading": true
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "ﺗﻘﺪم ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ إﱃ ﻇﻬﻮر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ ذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا، واﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ، واﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ",
      "extractCut": true
    },
    {
      "id": "sec-029-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "level": 4,
      "pageStart": 61,
      "pageEnd": 63,
      "labelStart": "55",
      "labelEnd": "57",
      "words": 561,
      "summary": {
        "text": "Sets out the core terms of reference for WHO H5 reference laboratories, designated case by case, including working under WHO's global influenza programme, testing H5 viruses and acknowledging contributing laboratories and countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
          "heading": false
        },
        {
          "term": "اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "اﻟﻌﻴﻨﺎت اﻟﴪﻳﺮﻳﺔ",
          "heading": false
        },
        {
          "term": "ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا وﻓريوﺳﺎت",
          "heading": false
        },
        {
          "term": "اﻟﻔريوﺳﺎت اﻟﺘﻲ",
          "heading": false
        }
      ],
      "extract": "ﻫﻲ ﻣﺨﺘﱪات ﻳﺘﻢ ﺗﻌﻴﻴﻨﻬﺎ مبﻮﺟﺐ إﺟﺮاءات ﻣﺤﺪدةH5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ ﺗﻀﻌﻬﺎ اﳌﻨﻈﻤﺔ، وﻋﲆ أﺳﺎس ﻇﺮﰲ، وﺗﻔﻲ ﺑﺎﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﻟﻮاردة أدﻧﺎه. أﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ :H5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ اﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ ١– )اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ ٢(؛ ﺑني اﻟﺒﴩ؛H5 اﺳﺘﻴﻔﺎء ﻣﻌﺎﻳري اﳌﻨﻈﻤﺔ ﺑﺸﺄن ﻗﺒﻮل اﻟﻨﺘﺎﺋﺞ اﻹﻳﺠﺎﺑﻴﺔ ﻟﻠﻌﺪوى",
      "extractCut": true
    },
    {
      "id": "sec-030-اﳌﺨﺘﱪات-اﻟﺘﻨﻈﻴﻤﻴﺔ-اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "title": "اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ",
      "level": 3,
      "pageStart": 63,
      "pageEnd": 65,
      "labelStart": "57",
      "labelEnd": "59",
      "words": 717,
      "summary": {
        "text": "An Arabic annex of the Pandemic Influenza Preparedness (PIP) Framework setting out the terms of reference for WHO Global Influenza Surveillance and Response System laboratories handling PIP biological materials, starting with general information on the network's four types of laboratories. It describes the roles of essential regulatory laboratories in the network. It ends with an editor's note clarifying that references to the standard material transfer agreement mean SMTA 1. The Arabic extraction uses presentation-form characters but is legible.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ",
          "heading": true
        },
        {
          "term": "اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ",
          "heading": true
        },
        {
          "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
          "heading": false
        },
        {
          "term": "ﻣﺨﺘﱪات ﺷﺒﻜﺔ",
          "heading": false
        },
        {
          "term": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
          "heading": false
        },
        {
          "term": "ﺗﻘﺪم ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﺗﺘﺒﺎدل ﻣﺨﺘﱪات",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        }
      ],
      "extract": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ ﻣﻦ ﻇﻬﻮر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ ذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
      "extractCut": true
    },
    {
      "id": "sec-031-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ",
      "number": null,
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "level": 4,
      "pageStart": 65,
      "pageEnd": 68,
      "labelStart": "59",
      "labelEnd": "182",
      "words": 598,
      "summary": {
        "text": "Lists, in Arabic, the core terms of reference that essential regulatory laboratories must meet, individually or collectively, under the Pandemic Influenza Preparedness Framework: general duties such as advising WHO on selecting H5N1 and other potentially pandemic viruses for vaccines, supporting preparedness plans, using the virus traceability mechanism and complying with the Standard Material Transfer Agreement. Laboratory activities include storing and developing candidate vaccine viruses, preparing, calibrating and supplying reference reagents and advising WHO on vaccine virus selection, while research duties cover involving and crediting scientists from originating countries; each item cites the relevant guiding principles, and the page ends with the ISBN and WHO's address.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﳌﺮﺷﺤﺔ",
          "heading": false
        },
        {
          "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻟﻨﻤﻂ اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
          "heading": false
        },
        {
          "term": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
          "heading": false
        },
        {
          "term": "اﳌﺒﺎدئ اﻟﺘﻮﺟﻴﻬﻴﺔ",
          "heading": false
        },
        {
          "term": "اﳌﺮﺷﺤﺔ اﻟﺘﻲ",
          "heading": false
        }
      ],
      "extract": "ﻳﺠﺐ أن ﺗﺴﺘﻮﰲ اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ ﻓﺮدﻳﺎً أو ﺟامﻋﻴﺎً اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﻟﻮاردة أدﻧﺎه: أﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ: وﻓريوﺳﺎت H5N1 إﺳﺪاء اﳌﺸﻮرة إﱃ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﺧﺘﻴﺎر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ ١– اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ، ﺑﻐﻴﺔ اﺳﺘﻌامﻟﻬﺎ ﰲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا )اﳌﺒﺎدئ اﻟﺘﻮﺟﻴﻬﻴﺔ ٢ و٣ و٥(؛ ﻣﺴﺎﻋﺪة اﳌﻨﻈﻤﺔ واﻟﺪول اﻷﻋﻀﺎء ﻋﲆ إﻋﺪاد اﻟﺠﻮاﻧﺐ ذات اﻟﺼﻠﺔ ﺑﺎﻟﻠﻘﺎﺣﺎت ﻣﻦ ﺧﻄﻂ اﻟﺘﺄﻫﺐ ٢– واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا",
      "extractCut": true
    }
  ],
  "checks": {
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 61,
      "items": [
        "p3: pdf-labels iii, printed i",
        "p4: pdf-labels iv, printed ii",
        "p5: pdf-labels v, printed iii",
        "p6: pdf-labels vi, printed iv",
        "p7: pdf-labels 121, printed 1",
        "p8: pdf-labels 122, printed 2",
        "p9: pdf-labels 123, printed 3",
        "p10: pdf-labels 124, printed 4",
        "p11: pdf-labels 125, printed 5",
        "p12: pdf-labels 126, printed 6",
        "p13: pdf-labels 127, printed 7",
        "p14: pdf-labels 128, printed 8",
        "p15: pdf-labels 129, printed 9",
        "p16: pdf-labels 130, printed 10",
        "p17: pdf-labels 131, printed 11",
        "p18: pdf-labels 132, printed 12",
        "p19: pdf-labels 133, printed 13",
        "p20: pdf-labels 134, printed 14",
        "p21: pdf-labels 135, printed 15",
        "p22: pdf-labels 136, printed 16",
        "p23: pdf-labels 137, printed 17",
        "p24: pdf-labels 138, printed 18",
        "p25: pdf-labels 139, printed 19",
        "p26: pdf-labels 140, printed 20",
        "p27: pdf-labels 141, printed 21",
        "p28: pdf-labels 142, printed 22",
        "p29: pdf-labels 143, printed 23",
        "p30: pdf-labels 144, printed 24",
        "p31: pdf-labels 145, printed 25",
        "p35: pdf-labels 149, printed 29",
        "p36: pdf-labels 150, printed 30",
        "p37: pdf-labels 151, printed 31",
        "p38: pdf-labels 152, printed 32",
        "p39: pdf-labels 153, printed 33",
        "p40: pdf-labels 154, printed 34",
        "p41: pdf-labels 155, printed 35",
        "p42: pdf-labels 156, printed 36",
        "p43: pdf-labels 157, printed 37",
        "p44: pdf-labels 158, printed 38",
        "p45: pdf-labels 159, printed 39",
        "p46: pdf-labels 160, printed 40",
        "p47: pdf-labels 161, printed 41",
        "p48: pdf-labels 162, printed 42",
        "p49: pdf-labels 163, printed 43",
        "p50: pdf-labels 164, printed 44",
        "p51: pdf-labels 165, printed 45",
        "p52: pdf-labels 166, printed 46",
        "p53: pdf-labels 167, printed 47",
        "p54: pdf-labels 168, printed 48",
        "p55: pdf-labels 169, printed 49"
      ]
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ",
      "heading": true
    },
    {
      "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "heading": true
    },
    {
      "term": "اﳌﻨﻈﻤﺔ اﻟﺘﻲ",
      "heading": false
    },
    {
      "term": "ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
      "heading": true
    },
    {
      "term": "اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى",
      "heading": true
    },
    {
      "term": "اﳌﻮاد اﻟﺘﻲ",
      "heading": false
    },
    {
      "term": "ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ",
      "heading": false
    },
    {
      "term": "اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻴﺔ",
      "heading": false
    },
    {
      "term": "ﻣﺨﺘﱪات اﻷﻧﻔﻠﻮﻧﺰا",
      "heading": false
    },
    {
      "term": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "heading": true
    },
    {
      "term": "ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا",
      "heading": false
    },
    {
      "term": "اﻷﻧﻔﻠﻮﻧﺰا مبﺎ",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "i",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "ii",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "i",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "ii",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 5,
      "label": "iii",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 6,
      "label": "iv",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 7,
      "label": "1",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 8,
      "label": "2",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 9,
      "label": "3",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 10,
      "label": "4",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 11,
      "label": "5",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 12,
      "label": "6",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 13,
      "label": "7",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 14,
      "label": "8",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 15,
      "label": "9",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 16,
      "label": "10",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 17,
      "label": "11",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 18,
      "label": "12",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 19,
      "label": "13",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 20,
      "label": "14",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 21,
      "label": "15",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 22,
      "label": "16",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 23,
      "label": "17",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 24,
      "label": "18",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 25,
      "label": "19",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 26,
      "label": "20",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 27,
      "label": "21",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 28,
      "label": "22",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 29,
      "label": "23",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 30,
      "label": "24",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 31,
      "label": "25",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 32,
      "label": "146",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 33,
      "label": "147",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 34,
      "label": "148",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 35,
      "label": "29",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 36,
      "label": "30",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 37,
      "label": "31",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 38,
      "label": "32",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 39,
      "label": "33",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 40,
      "label": "34",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 41,
      "label": "35",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 42,
      "label": "36",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 43,
      "label": "37",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 44,
      "label": "38",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 45,
      "label": "39",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 46,
      "label": "40",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 47,
      "label": "41",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 48,
      "label": "42",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 49,
      "label": "43",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 50,
      "label": "44",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 51,
      "label": "45",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 52,
      "label": "46",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 53,
      "label": "47",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 54,
      "label": "48",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 55,
      "label": "49",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 56,
      "label": "50",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 57,
      "label": "51",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 58,
      "label": "52",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 59,
      "label": "53",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 60,
      "label": "54",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 61,
      "label": "55",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 62,
      "label": "56",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 63,
      "label": "57",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 64,
      "label": "58",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 65,
      "label": "59",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 66,
      "label": "60",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 67,
      "label": "181",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 68,
      "label": "182",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 32,
      "note": "inferred"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 33,
      "note": "4 levels"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "found",
      "count": 5
    },
    {
      "kind": "summaries",
      "state": "partial",
      "count": 31,
      "note": "31 of 33 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-44796-ara"
  }
}
